IFNG and breast carcinoma: Furthermore, we classified the breast cancer samples in the TCGA cohort into five distinct immune subtypes: C1 (Wound Healing, 32%), C2 (IFN-gamma Dominant 51%), C3 (Inflammatory, 11%), C4 (Lymphocyte Depleted, 3%), and C6 (TGF-beta Dominant, 3%).